Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials

References

• Czaja CA, Scholes D, Hooton TM, et al. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80
   PubMed Web of Science ®Google Scholar
• Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003;13:144-50
   PubMed Web of Science ®Google Scholar
• Hodson EM, Willis NS, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev 2007;CD003772
   Google Scholar
• Brown P, Ki M, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 2005;23:1123-42
   PubMed Web of Science ®Google Scholar
• Kim K, Lee CC, Rhee JE, et al. The effects of an institutional care map on the admission rates and medical costs in women with acute pyelonephritis. Acad Emerg Med 2008;15:319-23
   PubMed Web of Science ®Google Scholar
• Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991;91:462-70
   PubMed Web of Science ®Google Scholar
• Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005;71:933-42
   PubMed Web of Science ®Google Scholar
• Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988;85:793-8
   PubMed Web of Science ®Google Scholar
• Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999;104:79-86
   PubMed Web of Science ®Google Scholar
• Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007;335:386
   PubMed Web of Science ®Google Scholar
• Ahmetagic S, Jusufovic E, Cengic D, et al. [Analysis of amoxicillin-clavulanic acid (Xiclav) efficacy and the possibility of early switch from parenteral to oral therapy in the treatment of infections]. Med Arh 2003;57:263-6
   PubMedGoogle Scholar
• McCracken GH. New era for orally administered antibiotics: use of sequential parenteral-oral antibiotic therapy for serious infectious diseases of infants and children. Pediatr Infect Dis J 1987;6:951-3
   PubMed Web of Science ®Google Scholar
• Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996;12:195-208
   PubMed Web of Science ®Google Scholar
• Bouissou F, Munzer C, Decramer S, et al. Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months. Pediatrics 2008;121:553-60
   PubMed Web of Science ®Google Scholar
• Noorbakhsh S, Lari AR, Masjedian F, et al. Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime in urinary tract infections. Saudi Med J 2004;25:1513-5
   PubMed Web of Science ®Google Scholar
• Benador D, Neuhaus TJ, Papazyan JP, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 2001;84:241-6
   PubMed Web of Science ®Google Scholar
• Levtchenko E, Lahy C, Levy J, et al. Treatment of children with acute pyelonephritis: a prospective randomized study. Pediatr Nephrol 2001;16:878-84
   PubMed Web of Science ®Google Scholar
• Vilaichone A, Watana D, Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children. J Med Assoc Thai 2001;84(Suppl 1):61-7
   Google Scholar
• François P, Bensman A, Bégué P, et al. Assessment of the efficacy and cost efficiency of two strategies in the treatment of acute pyelonephritis in children: oral cefixime or parenteral ceftriaxone after an initial i.v. combination therapy. Médecine et Maladies Infectieuses 1997;27:667-73
   Web of Science ®Google Scholar
• Bailey RR, Begg EJ, Smith AH, et al. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol 1996;46:183-6
   PubMed Web of Science ®Google Scholar
• Regnier B. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections]. Presse Med 1989;18:1617-21
   PubMed Web of Science ®Google Scholar
• Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database Syst Rev 2007;CD003237
   Google Scholar
• Bhatnagar V, Mitra DK, Agarwala S, et al. The role of DMSA scans in evaluation of the correlation between urinary tract infection, vesicoureteric reflux, and renal scarring. Pediatr Surg Int 2002;18:128-34
   PubMed Web of Science ®Google Scholar
• Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994;70:111-5
   PubMed Web of Science ®Google Scholar
• MacKenzie JR. A review of renal scarring in children. Nucl Med Commun 1996;17:176-90
   PubMed Web of Science ®Google Scholar
• Raz R, Sakran W, Chazan B, et al. Long-term follow-up of women hospitalized for acute pyelonephritis. Clin Infect Dis 2003;37:1014-20
   PubMed Web of Science ®Google Scholar
• Smellie JM, Shaw PJ, Prescod NP, et al. 99mTc dimercaptosuccinic acid (DMSA) scan in patients with established radiological renal scarring. Arch Dis Child 1988;63:1315-9
   PubMed Web of Science ®Google Scholar
• Ahmed M, Eggleston D, Kapur G, et al. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children. Pediatr Nephrol 2008;23:435-8
   PubMed Web of Science ®Google Scholar
• Jahnukainen T, Chen M, Celsi G. Mechanisms of renal damage owing to infection. Pediatr Nephrol 2005;20:1043-53
   PubMed Web of Science ®Google Scholar
• el-Khatib M, Packham DK, Becker GJ, et al. Pregnancy-related complications in women with reflux nephropathy. Clin Nephrol 1994;41:50-5
   PubMed Web of Science ®Google Scholar
• Hollowell JG. Outcome of pregnancy in women with a history of vesico-ureteric reflux. BJU Int. 2008; 102: 780-4
   PubMed Web of Science ®Google Scholar
• Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58
   PubMed Web of Science ®Google Scholar
• Jackson MA, Nelson JD. Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J Pediatr Orthop 1982;2:313-23
   PubMed Web of Science ®Google Scholar
• Tuomanen EI, Powell KR, Marks MI, et al. Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr 1981;99:968-74
   PubMed Web of Science ®Google Scholar
• Hagaman JT, Yurkowski P, Trott A, et al. Getting physicians to make “the switch”: the role of clinical guidelines in the management of community-acquired pneumonia. Am J Med Qual 2005;20:15-21
   PubMed Web of Science ®Google Scholar
• Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs 2008;31:39-45
   PubMedGoogle Scholar
• Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Acad Nurse Pract 2008;20:172-80
   PubMed Web of Science ®Google Scholar
• Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(Suppl 1A):13
   Google Scholar
• Pablos AI, Escobar I, Albinana S, et al. Evaluation of an antibiotic intravenous to oral sequential therapy program. Pharmacoepidemiol Drug Saf 2005;14:53-9
   PubMed Web of Science ®Google Scholar
• Mombelli G, Pezzoli R, Pinoja-Lutz G, et al. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999;159:53-8
   PubMed Web of Science ®Google Scholar
• Pangon B, Chaplain C. [Acute pyelonephritis: bacteriological data and general course of germ resistance]. Pathol Biol (Paris) 2003;51:503-7
   PubMed Web of Science ®Google Scholar
• Trinchiere A. [Role of levofloxacin in the treatment of urinary tract infections]. Arch Ital Urol Androl 2001;73:105-13
   PubMedGoogle Scholar
• Schaeffer AJ. The expanding role of fluoroquinolones. Dis Mon 2003;49:129-47
   PubMed Web of Science ®Google Scholar
• The use of systemic fluoroquinolones. Pediatrics 2006;118:1287–92
   PubMed Web of Science ®Google Scholar
• Cuzzolin L, Fanos V. Safety of fluoroquinolones in paediatrics. Expert Opin Drug Saf 2002;1:319-24
   PubMedGoogle Scholar